Wednesday, September 30, 2020 9:18:35 AM
9:00 AM ET 9/30/20 | Dow Jones
Collaboration Will Allow Care Providers on Amwell Platform to Remotely Examine Patients Using Streaming Information from Tyto Devices, Extending the Scope of Care Rendered at Home.
BOSTON, Sept. 30, 2020 /PRNewswire/ -- Amwell(R) (NYSE: AMWL), a national telehealth leader, today announced it is expanding its partnership with Tyto Care, the healthcare industry's first all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams. Together the companies will introduce exclusive integrations and newly designed workflows and tools to enhance the ability for providers using the Amwell platform to examine and diagnose patients virtually. Additionally, Amwell will become a reseller of Tyto Care's integrated devices.
By pairing the TytoHome handheld examination device -- which enables on-demand examinations of the heart, lungs, abdomen, skin, throat, ears, heart rate, and body temperature -- with Amwell's telehealth platform, providers can guide patients through virtual health examinations and together gain real-time insight into a patient's health data and status directly in the visit. For patients and providers, this will augment the virtual care experience and more broadly enrich the capabilities and overall satisfaction associated with healthcare organizations' virtual care applications. This enriched workflow will be available to thousands of Amwell hospitals, health systems, health plans and employer clients who collectively serve millions of patients.
"As COVID-19 wages on and more patients and providers adopt telehealth, it's critical that we accelerate the depth of care that can be provided in the home -- to keep patients and providers safe," said Roy Schoenberg, President and Co-CEO, Amwell. "Our latest integration with Tyto Care will allow providers to clinically come closer than ever before to patients during telehealth encounters, allowing them to see, interact, examine and deliver care in ways that growingly resemble in-person care."
"Our longstanding partnership with Amwell exemplifies our shared goal of providing deeply integrated telehealth solutions that put health in the hands of consumers, creating a more impactful and seamless healthcare experience for both patients and providers," said Dedi Gilad, CEO and Co-Founder, Tyto Care. "The integration with TytoHome will enable Amwell to offer more holistic care for patients, especially for urgent and primary care needs, as well as help to enable better adherence to treatment plans. We look forward to continuing our work together as we realize the full potential of clinic-quality, at-home care in this new era of telehealth."
Recent AMWL News
- AMWELL ANNOUNCES RESULTS FOR FIRST QUARTER 2024 • GlobeNewswire Inc. • 05/01/2024 08:05:00 PM
- Amwell Releases 2024 Corporate Responsibility Report • GlobeNewswire Inc. • 04/29/2024 11:00:00 AM
- Amwell to Participate in Upcoming Investor Conference • GlobeNewswire Inc. • 04/25/2024 11:00:00 AM
- Amwell® to Report First Quarter 2024 Operating Results May 1 • GlobeNewswire Inc. • 04/17/2024 11:00:00 AM
- Amwell Receives Continued Listing Standard Notice From NYSE • GlobeNewswire Inc. • 04/04/2024 08:05:00 PM
- Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024 • GlobeNewswire Inc. • 03/06/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:37:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:37:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:36:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:36:16 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 03/01/2024 10:12:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:48:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:47:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:46:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:45:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:07:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:05:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:03:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:01:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 11:40:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 11:39:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 11:38:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 11:37:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 11:36:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 10:11:57 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM